Have a personal or library account? Click to login
Two novel CEBPA mutations in a Turkish patient with acute myeloid leukemia Cover

Two novel CEBPA mutations in a Turkish patient with acute myeloid leukemia

Open Access
|Mar 2021

References

  1. De Kouchkovsky I, Abdul-Hay M. Acute myeloid leukemia: A comprehensive review and 2016 update. Blood Cancer J. 2016; 6(7): e441.
  2. Lin P, Falini B. Acute myeloid leukemia with recurrent genetic abnormalities other than translocations. Am J Clin Pathol. 2015; 144(1): 19-28.
  3. Schnittger S, Schoch C, Dugas M. Analysis of FLT3 length mutations in 1003 patients with acute myeloid leukemia: Correlation to cytogenetics, FAB subtype, and prognosis in the AMLCG study and usefulness as a marker for the detection of minimal residual disease. Blood. 2002; 100(1): 59-67.
  4. Li GX, Wang L, Yaghmour B, Ramshingh G, Yaghmour G. The role of FLT3 inhibitors as maintenance therapy following hematopoietic stem cell transplant. Leuk Res Rep. 2018; 10: 26-36.
  5. Thiede C, Koch S, Creutzig E, Steudel C, Illmer T, Schaich M, et al. Prevalence and prognostic impact of NPM1 mutations in 1485 adult patients with acute myeloid leukemia (AML). Blood. 2006; 107(10): 4011-4020.
  6. Geletu M, Balkhi MY, Peer Zada AA Christopeit M, Pulikkan JA, Trivedi AK, et al. Target proteins of C/ EB Pap30 in AML: C/EBPap30 enhances sumoylation of C/EB Pap42 via up-regulation of Ubc9. Blood. 2007; 110(9): 3301-3309.
  7. Pastore F, Kling D, Hoster E, Dufour A, Konstandin NP, Schneider S, et al. Long-term follow-up of cytogenetically normal CEBPA-mutated AML. J Hematol Oncol. 2014; 7(1): 1-8.
  8. Leroy H, Roumier C, Huyghe P, Biggio V, Fenaux P, Preudhomme C. CEBPA point mutations in hematological malignancies. Leukemia. 2005; 19(3): 329-334.
  9. Hughes JM, Legnini I, Salvatori B, Masciarelli S, Marchioni M, Fazi F, et al. C/EBPα-p30 protein induces expression of the oncogenic long non-coding RNA UCA1 in acute myeloid leukemia. Oncotarget. 2015; 6(21): 18534-18544.
  10. Tawana K, Rio-Machin A, Preudhomme C, Fitzgibbon J. Familial CEBPA-mutated acute myeloid leukemia. Semin Hematol. 2017; 54(2): 87-93.
  11. Kim S, Kim DH, Jang JH, Jung CW, Jang MA, Ki CS, et al. Novel mutations in CEBPA in Korean patients with acute myeloid leukemia with a normal karyotype. Ann Lab Med. 2012; 32(2): 153-157.
  12. Ram J, Flamm G, Balys M, Sivagnanalingam U, Rothberg PG, Iqbal A, et al. Index case of acute myeloid leukemia in a family harboring a novel CEBPA germ line mutation. Blood Adv. 2017; 1(8): 500-503.
Language: English
Page range: 99 - 102
Published on: Mar 23, 2021
In partnership with: Paradigm Publishing Services
Publication frequency: 2 issues per year

© 2021 PE Tokgun, MT Alay, S Atli Tekin, N Güler, O Tokgun, A Demiray, N Karagenc, T Durak, B Celik, H Akca, published by Macedonian Academy of Sciences and Arts
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.